Life Molecular Imaging SA
Quick facts
Phase 3 pipeline
- Florbetaben (BAY94-9172) · Neurology / Diagnostic Imaging
Florbetaben is a fluorine-18 labeled imaging agent that binds to amyloid-beta plaques in the brain for positron emission tomography (PET) detection.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Life Molecular Imaging SA
What is Life Molecular Imaging SA's pipeline?
Life Molecular Imaging SA has 1 drugs in Phase 3, 0 in Phase 2, 4 in Phase 1. Late-stage candidates include Florbetaben (BAY94-9172).
Related
- Sector hub: All tracked pharma companies